Citation: | ZHOU Xingqin, ZHAO Hongyu, SONG Yao, CHEN Wenjuan, SHEN Chaoyan, JI Bin. Therapeutic Effect of Elemene Combined with Chemoradiotherapy and Its Influence on Immune Function in Nasopharyngeal Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1118-1122. DOI: 10.3971/j.issn.1000-8578.2019.19.0669 |
To observe the therapeutic effect of elemene emulsion injection combined with chemoradiotherapy and its effect on immune function in nasopharyngeal carcinoma (NPC) patients.
Random number method was used to divide the patients into control group (IMRT+fluorouracil+cisplatin) and observation group (IMRT+fluorouracil+cisplatin+elemene injection 500 mg/d). We evaluated the short-term efficacy, the changes of T lymphocyte subsets in peripheral blood and adverse reactions.
All patients successfully completed the treatment. There was statistically significant difference between control group and observation group in the total effective rate (71.74% vs. 82.61%, P < 0.05), CD8+ level in peripheral blood lymphocyte subsets (31.35±2.39 vs. 34.37±1.97, P < 0.05), the ratio of CD4+/CD8+ (1.37±0.03 vs. 0.98±0.18, P < 0.05), and the quality of life (57.2±7.4 vs. 60.3±5.3, P < 0.05). Compared with control group, the observation group had lower hematological toxicity and grade Ⅲ-Ⅳ skin reactions, and the incidence of grade Ⅲ-Ⅳ gastrointestinal reactions (nausea, vomiting) was significantly lower (P < 0.05).
Elemene combined with chemoradiotherapy could improve the quality of life of nasopharyngeal carcinoma patients, reduce the incidence of adverse reactions and obtain a better prognosis.
[1] |
Mott FE, Ferrarotto R, Nguyen T, et al. Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy[J]. Oral Oncol, 2018, 81: 75-80. doi: 10.1016/j.oraloncology.2018.04.020
|
[2] |
Wang M, Xu Y, Chen X, et al. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy[J]. J Cancer Res Ther, 2016, 12(2): 909-914. doi: 10.4103/0973-1482.168969
|
[3] |
Jiang X, Hidru TH, Zhang Z, et al. Evidence of elemene injection combined radiotherapy in lung cancer treatment among patients with brain metastases: A systematic review and meta-analysis[J]. Medicine(Baltimore), 2017, 96(21): e6963. http://cn.bing.com/academic/profile?id=f2f36fabea943d4e004f1b48ed997416&encoded=0&v=paper_preview&mkt=zh-cn
|
[4] |
Li LJ, Zhong LF, Jiang LP, et al. β-Elemene Radiosensitizes Lung Cancer A549 Cells by Enhancing DNA Damage and Inhibiting DNA Repair[J]. Phytother Res, 2011, 25(7): 1095-1097. doi: 10.1002/ptr.3367
|
[5] |
Yao YQ, Ding X, Jia YC, et al. Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation[J]. Cancer Lett, 2008, 264(1): 127-134. doi: 10.1016-j.canlet.2008.01.049/
|
[6] |
Liu JS, He SC, Zhang ZL, et al. Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: A proteomic study[J]. Oncol Rep, 2014, 32(6): 2635-2647. doi: 10.3892/or.2014.3490
|
[7] |
王跃建.鼻咽癌诊断和治疗[M].北京:人民卫生出版社, 2013, 288-307.
Wang YJ. Diagnosis and treatment of nasopharyngeal carcinoma[M]. Beijing: People's Health Publishing House, 2013, 288-307.
|
[8] |
中国鼻咽癌临床分期工作委员会. 2010鼻咽癌调强放疗靶区及剂量设计指引专家共识[J].中华放射肿瘤学杂志, 2011, 20(4): 267-269. doi: 10.3760/cma.j.issn.1004-4221.2011.04.001
Working committee for the clinical stage nasopharyngealcarcinoma (NPC) in China. 2010 expert consensus of nasopharyngeal carcinoma IMRT target and dosage design[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2011, 20(4): 267-269. doi: 10.3760/cma.j.issn.1004-4221.2011.04.001
|
[9] |
Tang LQ, Chen DP, Guo L, et al. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage Ⅱ-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial[J]. Lancet Oncol, 2018, 19(4): 461-473. doi: 10.1016/S1470-2045(18)30104-9
|
[10] |
Shimada M, Itamochi H, Kigawa J. Nedaplatin: a cisplatin derivative in cancer chemotherapy[J]. Cancer Manag Res, 2013, 5: 67-76. http://d.old.wanfangdata.com.cn/Periodical/zl201106011
|
[11] |
Chen L, Liu LZ, Chen M, et al. Prognostic value of subclass-sification using MRI in the T4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment[J]. Int J Radiat Oncol Biol Phys, 2012, 84(1): 196-202. doi: 10.1016/j.ijrobp.2011.11.021
|
[12] |
Petersson F. Nasopharyngeal carcinoma: a review[J]. Semin Diagn Pathol, 2015, 32(1): 54-73. doi: 10.1053/j.semdp.2015.02.021
|
[13] |
谭明, 廖天志, 向东华.调强适形放疗对鼻咽癌患者治疗效果及免疫功能的影响[J].癌症进展, 2019, 17(3): 308-310. http://d.old.wanfangdata.com.cn/Periodical/azjz201903015
Tan M, Liao TZ, Xiang DH. The clinical efficacy of IMRT and the influence on immune function of patients with nasopharyngeal carcinoma[J]. Ai Zheng Jin Zhan, 2019, 17(3): 308-310. http://d.old.wanfangdata.com.cn/Periodical/azjz201903015
|
[14] |
杨娜, 郭启帅, 汪春雨, 等.基于Meta分析同步放化疗比单纯放疗治疗晚期鼻咽癌更有效[J].基因组学与应用生物学, 2018, 37(1): 164-169. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jyzxyyyswx201801025
Yang N, Guo QS, Wang CY, et al. The Concurrent Chemoradiation is More Effective than Radiation Alone in the Treatment of Advanced Nasopharyngeal Carcinoma Based on Meta-analysis[J]. Ji Yin Zu Xue Yu Ying Yong Sheng Wu Xue, 2018, 37(1): 164-169. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jyzxyyyswx201801025
|
[15] |
Chen W, Lu Y, Wu J, et al. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis[J]. Cancer Chemother Pharmacol, 2011, 67(4): 799-808. doi: 10.1007/s00280-010-1378-x
|
[16] |
Wu J, Tang Q, Yang L, et al. Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells[J]. Sci Rep, 2017, 7(1): 509. doi: 10.1038/s41598-017-00626-6
|
[17] |
Liu J. Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis[J]. Front Med, 2011, 5(1): 101-105. doi: 10.1007/s11684-011-0111-4
|
[18] |
周云, 万丹影, 钱晓倩, 等.榄香烯注射液联合吉非替尼改善表皮生长因子受体突变非小细胞肺癌晚期患者免疫功能及生活质量的效果[J].中国临床保健杂志, 2017, 20(5): 502-505. doi: 10.3969/J.issn.1672-6790.2017.05.006
Zhou Y, Wan DY, Qian XQ, et al. Effect of elemene injection combined with gefitinib on immune function and life quality of advanced elder lung cancer patients with EGFR mutant[J]. Zhongguo Lin Chuang Bao Jian Za Zhi, 2017, 20(5): 502-505. doi: 10.3969/J.issn.1672-6790.2017.05.006
|
[19] |
雷俊华, 刘韵, 曾江正, 等.榄香烯注射液联合化疗对晚期非小细胞肺癌患者免疫功能及疗效的影响[J].临床肿瘤学杂志, 2018, 23(2): 160-163. doi: 10.3969/j.issn.1009-0460.2018.02.013
Lei JH, Liu Y, Zeng JZ, et al. Influence of Elemene Injection plus chemotherapy on the immune function and curative effect in patients with advanced non-small cell lung cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2018, 23(2): 160-163. doi: 10.3969/j.issn.1009-0460.2018.02.013
|